Dr. Gyaw is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6001 Rockville Pike
Ste 4123
Bethesda, MD 20892Phone+1 301-443-2281
Education & Training
MedStar Health/Harbor HospitalResidency, Internal Medicine, 1998 - 2001
University Institute of Medicine 1Class of 1985
Certifications & Licensure
MD State Medical License 1999 - 2026
MI State Medical License 2004 - 2020- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Oral Civamide Safety, Tolerability First in Human Study Start of enrollment: 2008 Nov 01
- Lorcaserin in the Treatment of Cocaine Use Disorder Start of enrollment: 2017 Dec 19
Publications & Presentations
PubMed
- 3 citationsResults of a randomized, double-blind, placebo-controlled trial of lorcaserin in cocaine use disorder.David J McCann, Hegang H Chen, Eric G Devine, Shwe Gyaw, Tatiana Ramey
Drug and Alcohol Dependence. 2024-02-01 - 27 citationsFighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid OverdosePhilip Krieter, Shwe Gyaw, Roger Crystal, Phil Skolnick
The Journal of Pharmacology and Experimental Therapeutics. 2019-11-01 - 22 citationsComparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxo...Philip Krieter, C. Nora Chiang, Shwe Gyaw, David J. McCann
Journal of Clinical Pharmacology. 2019-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
